Keywords: emea, updates, label, novartis, zometa, says, received

EMEA updates label for Novartis' Zometa

Article | 23 June 2003

Print This

Novartis says that it has received approval from the European Medicines Evaluation Agency to expand the current marketing authorization for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in